Global Lab Automation in Proteomics Market Strategic Research Report

Scope of the Report

The global Lab Automation in Proteomics market size is predicted to grow from US$ 3,036 million in 2025 to US$ 4,604 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.

The global key players of lab automation in proteomics include Thermo Fisher, Beckman Coulter (Danaher), Agilent Technologies, PerkinElmer, Roche, Siemens Healthineers, BD, and Waters, etc. The global top 8 players hold a share over 60%. North America is the largest producer, has a share about 50%, followed by Europe, with a share about 30%. In terms of product type, analytical automation segment occupies for over 60%, while in terms of end users, biotechnology and pharmaceutical companies are the largest segment, with a share over 40%.

This report presents a comprehensive overview of the global Lab Automation in Proteomics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Pre-analytical Automation
• Analytical Automation
• Post-analytical Automation
• Total Lab Automation

Segment by Application

• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Lab Automation in Proteomics market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact